Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Temporal analysis of mRNA expression profiles in Orientia infected C3HeB/FeJ mouse
  2. Chao, Chien-Chung; Yang, Ruoting; Zhang, Zhiwen; Belinskaya, Tatyana; Chan, Chye-Teik; Miller, Stacy-Ann; Hammamieh, Rasha; Jett, Marti; Ching, Wei-Mei
  3. BMC microbiology. 2020, Jan 06; 20(1): 3.
  1. 2.   PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
  2. Gryder, Berkley E.; Yohe, Marielle E.; Chou, Hsien-Chao; Zhang, Xiaohu; Marques, Joana; Wachtel, Marco; Schaefer, Beat; Sen, Nirmalya; Song, Young; Gualtieri, Alberto; Pomella, Silvia; Rota, Rossella; Cleveland, Abigail; Wen, Xinyu; Sindiri, Sivasish; Wei, Jun S.; Barr, Frederic G.; Das, Sudipto; Andresson, Thorkell; Guha, Rajarshi; Lal-Nag, Madhu; Ferrer, Marc; Shern, Jack F.; Zhao, Keji; Thomas, Craig J.; Khan, Javed
  3. Cancer Discovery. 2017, Aug; 7(8): 884-899.
  1. 3.   MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer
  2. Xiong, Y.; Zhang, L.; Holloway, A. K.; Wu, X. L.; Su, L.; Kebebew, E.
  3. Plos One. 2011, Oct; 6(10): 11.
  1. 4.   Quality Assessment of Microarray Data in a Multicenter Study
  2. Archer, K. J.; Mas, V. R.; O'Brien, T. R.; Pfeiffer, R.; Lum, N. L.; Fisher, R. A.
  3. Diagnostic Molecular Pathology. 2009 18(1): 34-43.
  1. 5.   Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen
  2. Amundson, S. A.; Do, K. T.; Vinikoor, L. C.; Lee, R. A.; Koch-Paiz, C. A.; Ahn, J.; Reimers, M.; Chen, Y.; Scudiero, D. A.; Weinstein, J. N.; Trent, J. M.; Bittner, M. L.; Meltzer, P. S.; Fornace, A. J.
  3. Cancer Research. 2008 68(2): 415-424.
  1. 6.   Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): Novel marker for cervical carcinogenesis
  2. Miyatake, T.; Ueda, Y.; Nakashima, R.; Yoshino, K.; Kimura, T.; Murata, T.; Nomura, T.; Fujita, M.; Buzard, G. S.; Enomoto, T.
  3. International Journal of Cancer. 2007, May; 120(10): 2068-2077.
  1. 7.   Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to zidovudine
  2. Divi, R. L.; Haverkos, K. J.; Humsi, J. A.; Shockley, M. E.; Thamire, C.; Nagashima, K.; Olivero, O. A.; Poirier, M. C.
  3. Environmental and Molecular Mutagenesis. 2007, Apr-May; 48(3-4): 179-189.
  1. 8.   Molecular alterations in primary prostate cancer after androgen ablation therapy
  2. Best, C. J. M.; Gillespie, J. W.; Yi, Y. J.; Chandramouli, G. V. R.; Perlmutter, M. A.; Gathright, Y.; Erickson, H. S.; Georgevich, L.; Tangrea, M. A.; Duray, P. H.; Gonzalez, S.; Velasco, A.; Linehan, W. M.; Matusik, R. J.; Price, D. K.; Figg, W. D.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Clinical Cancer Research. 2005, OCT 1; 11(19, Part 1): 6823-6834.
  1. 9.   Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis
  2. Cheng, R. Y. S.; Birely, L. A.; Lum, N. L.; Perella, C. M.; Cherry, J. M.; Bhat, N. K.; Kasprzak, K. S.; Powell, D. A.; Alvord, W. G.; Anderson, L. M.
  3. Journal of Molecular Endocrinology. 2004 32(1): 257-278.
  1. 10.   Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic
  2. Liu, J.; Xie, Y. X.; Ward, J. M.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicological Sciences. 2004 77(2): 249-257.
  1. 11.   Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine
  2. Pettit, G. R.; Hoffmann, H.; Herald, D. L.; Blumberg, P. M.; Hamel, E.; Schmidt, J. M.; Chang, Y.; Pettit, R. K.; Lewin, N. E.; Pearce, L. V.
  3. Journal of Medicinal Chemistry. 2004 47(7): 1775-1782.
  1. 12.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 13.   Probe generation directly from small numbers of cells for DNA microarray studies
  2. Xiang, C. C.; Chen, M.; Kozhich, O. A.; Phan, Q. N.; Inman, J. M.; Chen, Y.; Brownstein, M. J.
  3. Biotechniques. 2003 34(2): 386-+.
  1. 14.   Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5- fluorobenzothiazole
  2. Monks, A.; Harris, E.; Hose, C.; Connelly, J.; Sausville, E. A.
  3. Molecular Pharmacology. 2003 63(3): 766-772.
  1. 15.   Evaluation of gene expression measurements from commercial microarray platforms
  2. Tan, P. K.; Downey, T. J.; Spitznagel, E. L.; Xu, P.; Fu, D.; Dimitrov, D. S.; Lempicki, R. A.; Raaka, B. M.; Cam, M. C.
  3. Nucleic Acids Research. 2003 31(19): 5676-5684.
  1. 16.   A new strategy to amplify degraded RNA from small tissue samples for microarray studies - art. no. 53
  2. Xiang, C. C.; Chen, M.; Ma, L.; Phan, Q. N.; Inman, J. M.; Kozhich, O. A.; Brownstein, M. J.
  3. Nucleic Acids Research. 2003 31(9): art. no.-e53.
  1. 17.   Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles
  2. Yim, S. H.; Ward, J. M.; Dragan, Y.; Yamada, A.; Scacheri, P. C.; Kimura, S.; Gonzalez, F. J.
  3. Toxicologic Pathology. 2003 31(3): 295-303.
  1. 18.   PubMatrix: a tool for multiplex literature mining
  2. Becker, K. G.; Hosack, D. A.; Dennis, G.; Lempicki, R. A.; Bright, T. J.; Cheadle, C.; Engel, J.
  3. Bmc Bioinformatics. 2003 4: art-61.
  1. 19.   Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium(III) chloride
  2. Cheng, R. Y. S.; Alvord, W. G.; Powell, D.; Kasprzak, K. S.; Anderson, L. M.
  3. Reproductive Toxicology. 2002 16(3): 223-236.
  1. 20.   Amine-modified random primers to label probes for DNA microarrays
  2. Xiang, C. C.; Kozhich, O. A.; Chen, M.; Inman, J. M.; Phan, Q. N.; Chen, Y. D.; Brownstein, M. J.
  3. Nature Biotechnology. 2002 20(7): 738-742.
  1. 21.   Initiating oncogenic event determines gene-expression patterns of human breast cancer models
  2. Desai, K. V.; Xiao, N.; Wang, W.; Gangi, L.; Greene, J.; Powell, J. I.; Dickson, R.; Furth, P.; Hunter, K.; Kucherlapati, R.; Simon, R.; Liu, E. T.; Green, J. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(10): 6967-6972.
  1. 22.   Proteomic profiling of the cancer microenvironment by antibody arrays
  2. Knezevic, V.; Leethanakul, C.; Bichsel, V. E.; Worth, J. M.; Prabhu, V. V.; Gutkind, J. S.; Liotta, L. A.; Munson, P. J.; Petricoin, E. F.; Krizman, D. B.
  3. Proteomics. 2001 1(10): 1271-1278.
  1. 23.   An informatics approach identifying markers of chemosensitivity in human cancer cell lines
  2. Amundson, S. A.; Myers, T. G.; Scudiero, D.; Kitada, S.; Reed, J. C.; Fornace, A. J.
  3. Cancer Research. 2000 60(21): 6101-6110.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel